St. Louis, MO, United States of America

Tomas Hode

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tomas Hode: Innovator in Chitosan-Derived Therapeutics

Introduction

Tomas Hode, based in St. Louis, MO, is a prominent inventor known for his contributions to the field of medicinal therapies. With a total of three patents to his name, Hode has made significant advancements, particularly in the development of chitosan-derived compositions that have applications in treating various types of neoplasms.

Latest Patents

Hode's latest patents focus on therapeutic compositions derived from chitosan. These compositions are particularly useful in methods for treating malignant neoplasms, including but not limited to lung, thyroid, and kidney cancers. His patents underscore the potential of chitosan as a vital agent in medical treatments, offering hope for innovative strategies in oncology and other medical disorders.

Career Highlights

As a key figure at Immunophotonics, Inc., Tomas Hode has dedicated his career to advancing the science of therapeutic compositions. His work exemplifies a commitment to leveraging innovative materials for the betterment of medical science, particularly in cancer treatment.

Collaborations

Throughout his career, Hode has collaborated with esteemed colleagues such as Robert E. Nordquist and Wei R. Chen. Their joint efforts have furthered the research and development of chitosan-based therapies, highlighting the importance of teamwork in scientific discoveries and innovations.

Conclusion

Tomas Hode's contributions to the field of therapeutics through his patented inventions illustrate the impact of innovative research on medical treatment solutions. His work at Immunophotonics, Inc. continues to pave the way for future advancements in the fight against cancer and other serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…